The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen

被引:30
作者
Piérard, GE [1 ]
Piérard-Franchimont, C [1 ]
Arrese, JE [1 ]
机构
[1] Univ Liege, Dept Dermatopathol, Liege, Belgium
关键词
nail; onychomycosis; Sabouraud's agar; fungus;
D O I
10.1159/000018363
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Modern treatments for onychomycosis do not yield an ideal cure rate. Objective: The boosted oral antifungal treatment (BOAT) is introduced as a novel approach improving the efficacy of oral treatment with the itraconazole pulse dosing regimen. Method: The BOAT design targets resting fungal cells in order to produce sensitive hyphae which are less refractory to antifungals. This is performed by securing a piece of a Sabouraud's agar slide onto the affected nail in alternance with oral intake of itraconazole. Results: The present comparative intraindividual trial suggests that BOAT improves the mycological cure rate compared to the regular treatment. Conclusion: BOAT is a promising simple and cheap combined therapy for onychomycosis. However, the present pilot study calls for further clinical investigations. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:185 / 187
页数:3
相关论文
共 10 条
[1]   Facing up to the diagnostic uncertainty and management of onychomycoses [J].
Arrese, JE ;
Piérard-Franchimont, C ;
Piérard, GE .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 :1-6
[2]   Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overview [J].
De Doncker, P ;
Gupta, AK ;
Marynissen, G ;
Stoffels, P ;
Heremans, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (06) :969-974
[3]   Antifungal pulse therapy for onychomycosis - A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole [J].
DeDoncker, P ;
Decroix, J ;
Pierard, GE ;
Roelant, D ;
Woestenborghs, R ;
Jacqmin, P ;
Odds, F ;
Heremans, A ;
Dockx, P ;
Roseeuw, D .
ARCHIVES OF DERMATOLOGY, 1996, 132 (01) :34-41
[4]   Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients [J].
DeDoncker, PRG ;
Scher, RK ;
Baran, RL ;
Decroix, J ;
Degreef, HJ ;
Roseeuw, DI ;
Havu, V ;
Rosen, T ;
Gupta, AK ;
Pierard, GE .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (02) :173-177
[5]  
Gupta AK, 1999, J EUR ACAD DERMATOL, V13, P1
[6]  
Havu V, 1999, BRIT J DERMATOL, V140, P96, DOI 10.1046/j.1365-2133.1999.02614.x
[7]  
Hay RJ, 1999, INT J DERMATOL, V38, P65
[8]   Pharmacokinetics and pharmacology of terbinafine and itraconazole [J].
Leyden, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (05) :S42-S47
[9]   Treatment and prophylaxis of tinea infections [J].
Pierard, GE ;
Arrese, JE ;
PierardFranchimont, C .
DRUGS, 1996, 52 (02) :209-224
[10]  
PIERARD GE, IN PRESS MED MYCOL